The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

BIOG BIOTECH GROWTH TRUST (THE) PLC ORD 25P




We are now using data from FTSE Russell Data Solutions. FTSE Russell is a leading global provider of benchmarks, analytics and data solutions with multi-asset capabilities. Global Company Fundamentals provides profiles on global active and inactive companies from over 100 countries including over 25 years of as-reported financials and standardised financials based on globally accepted XBRL taxonomies for active companies. As a result of this change in data provider, you may see some differences to the data. For further information please contact lse-website@lseg.com
Income Statement 31-Mar-14
( £ m )
31-Mar-15
( £ m )
31-Mar-16
( £ m )
31-Mar-17
( £ m )
31-Mar-18
( £ m )
Continuing Operations
Revenue  0.87 0.99 1.82 1.90 1.58
Operating Profit/(Loss)  86.52 214.55 -128.36 98.86 -29.05
Net Interest  -0.09 -0.16 -0.34 -0.28 -0.49
Profit Before Tax  86.43 214.39 -128.70 98.58 -29.54
Profit After Tax  86.34 214.26 -128.95 98.30 -29.78
Discontinued Operations
Profit After Tax  n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD  86.34 214.26 -128.95 98.30 -29.78
Attributable to:
Minority Interests  n/a n/a n/a n/a n/a
Equity Holders of Parent Company  86.34 214.26 -128.95 98.30 -29.78
 
Continuing EPS
Earnings per Share - Basic  126.80p 328.00p -208.10p 171.50p -53.30p
Earnings per Share - Diluted  126.80p 328.00p -208.10p 171.50p -53.30p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  126.80p 328.00p -208.10p 171.50p -53.30p
Earnings per Share - Diluted  126.80p 328.00p -208.10p 171.50p -53.30p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  n/a n/a n/a n/a n/a

Balance Sheet 31-Mar-14
( £ m )
31-Mar-15
( £ m )
31-Mar-16
( £ m )
31-Mar-17
( £ m )
31-Mar-18
( £ m )
Assets
Non-Current Assets
Property, Plant & Equipment  n/a n/a n/a n/a n/a
Intangible Assets  n/a n/a n/a n/a n/a
Investment Properties  n/a n/a n/a n/a n/a
Investments  368.36 583.21 420.43 461.38 445.67
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  368.36 583.21 420.43 461.38 445.67
Current Assets
Inventories  n/a n/a n/a n/a n/a
Trade & Other Receivables  12.07 3.32 4.72 0.12 0.39
Cash at Bank & in Hand  n/a n/a n/a n/a n/a
Current Asset Investments  n/a n/a n/a n/a n/a
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  12.07 3.32 4.72 0.12 0.41
 
Total Assets  380.43 586.53 425.14 461.50 446.07
 
Liabilities
Current Liabilities
Borrowings  n/a 48.38 36.19 13.08 22.12
Other Current Liabilities  n/a 3.00 10.39 1.24 6.56
  40.19 53.23 46.58 14.32 28.68
 
Net Current Assets  -28.11 -49.91 -41.86 -14.20 -28.27
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  n/a n/a n/a n/a n/a
  n/a n/a n/a n/a n/a
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  40.19 53.23 46.58 14.32 28.68
 
Net Assets  340.25 533.30 378.57 447.18 417.40
 
Capital & Reserves
Share Capital  17.22 17.22 15.07 13.96 13.96
Share Premium Account  42.73 43.02 43.02 43.02 43.02
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  n/a n/a n/a n/a n/a
Shareholders Funds  340.25 533.30 378.57 447.18 417.40
 
Minority Interests/Other Equity  n/a n/a n/a n/a n/a
Total Equity *   340.25 533.30 378.57 447.18 417.40

Ratios - based on IFRS 31-Mar-14 31-Mar-15 31-Mar-16 31-Mar-17 31-Mar-18
Continuing Operations
PE Ratio *   3.68 2.42 n/a 4.36 n/a
PEG *   0.78 0.02 n/a n/a n/a
Earnings per Share Growth  4.71% 158.68% n/a n/a n/a
Dividend Cover *   n/a n/a n/a n/a n/a
Revenue Per Share  1.28p 1.51p 2.93p 3.32p 2.82p
Pre-Tax Profit per Share  126.89p 328.22p -207.10p 171.99p -52.91p
Operating Margin  9911.23% 21715.49% -7052.47% 5189.40% -1843.53%
Return on Capital Employed  29.84% 46.54% -25.69% 22.60% -6.46%
 
Continuing & Discontinued Operations
Dividend Yield *   n/a n/a n/a n/a n/a
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  498.72p 834.74p 627.85p 800.82p 747.49p
Net Gearing *   n/a n/a n/a n/a n/a

Data provided by FTSE Russell



Market

Company Information
Company website http://www.biotechgt.co...
Company address 25 Southampton Buildings, London, WC2A 1AL, United Kingdom
FTSE ICB sector Equity Investment Instruments
FTSE ICB subsector Equity Investment Instruments
Company market cap, £m* 438.90
Admission date 23 Jun 1997
*The market capitalisation of companies reflects the London listed element only and are approximate. Data provided by FTSE Russell.

Security Information
21-Jun-18
FTSE index FTSE All-Share,FTSE SmallCap
Market Main Market
Market identifier code (MIC) XLON
Trading service SETS
Trading segment SSMM
Listing category Premium Equity Closed Ended Investment Funds
Country of share register GB
ISIN GB0000385517
SEDOL 0038551
Exchange market size 500
Security market cap, £m 438.90



BIOTECH GWTH share fundamentals (BIOG)